Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0001193125-26-295004

Chief Executive Officer acquired 3,880 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Weis Holger Chief Executive Officer 2026-06-30 Grant or award +3,880 $2.26 $8,769 16,552 D
Loading xslF345X06/ownership.xml…